Organoids Market to Reach $10.76 Billion by 2029, Growing at a CAGR of 22.2%

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Market Value Is The Organoids Industry Expected To Reach By 2029, Starting From 2025 Levels?

The organoids market has experienced substantial growth in recent years. It is anticipated to expand from $3.98 billion in 2024 to $4.82 billion in 2025, achieving a compound annual growth rate (CAGR) of 21.0%. Historically, this market expansion can be attributed to advances in biomedical research, the demands of drug discovery and development, requirements for disease modeling, trends toward personalized medicine, and favorable regulatory support.

The organoids market is projected for rapid expansion over the coming years. This market is anticipated to reach $10.76 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 22.2%. This projected growth can be ascribed to several factors, including the rising incidence of chronic diseases, progress in genome editing techniques, an increase in stem cell research, strategic collaborations and partnerships, and ongoing clinical translation initiatives. Key trends during this period are expected to encompass applications within regenerative medicine, the development of in vivo imaging techniques, cooperative efforts for multi-organoid systems, addressing ethical and legal considerations, along with continued commercialization and market expansion.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10787&type=smp

What Are The Drivers Pushing New Developments In The Organoids Market?

The future expansion of the organoid market is anticipated to be driven by a rise in the occurrence and spread of chronic and infectious diseases. Chronic conditions are defined as ailments persisting beyond a year, necessitating continuous medical management. Organoids provide prompt and reliable insights into pathogen biology and drug screening, making them valuable tools for investigating diverse chronic illnesses and their therapies. Consequently, the growing frequency and widespread nature of chronic and infectious diseases will bolster the organoid market. As an illustration, figures from June 2024, released by the National Health Service, a UK-based publicly funded healthcare provider, indicated that 3,615,330 individuals registered with a GP were diagnosed with non-diabetic hyperglycemia, also known as pre-diabetes, in 2023. This represents a significant rise of almost a fifth (18%) from the 3,065,825 recorded in 2022. This upward trend in chronic disease prevalence will thus act as a catalyst for the organoid market.

What Are The Major Segment Categories Driving The Organoids Market Growth?

The organoidsmarket covered in this report is segmented –

1) By Product: Hepatic Organoid; Colorectal Organoid; Intestinal Organoid; Other Organoid

2) By Source: Pluripotent Stem Cells; Organ-Specific Adult Stem Cells

3) By Application: Developmental Biology; Disease Pathology Of Infectious Disease; Regenerative Medicine; Drug Toxicity And Efficacy Testing; Drug Discovery And Personalized Medicine; Other Applications

4) By End-User: Hospitals And Diagnostic Centers; Biotechnology And Pharmaceutical Companies; Other End-Users

Subsegments:

1) By Hepatic Organoid: Hepatic Stem Cell-Derived Organoids; Primary Liver Cell-Derived Organoids; Liver Tumor Organoids

2) By Colorectal Organoid: Colonic Organoids; Rectal Organoids; Colorectal Cancer Organoids

3) By Intestinal Organoid: Small Intestinal Organoids; Enteroid Organoids; Intestinal Stem Cell-Derived Organoids

4) By Other Organoid: Pancreatic Organoids; Brain Organoids; Kidney Organoids; Lung Organoids; Others

What Are The Major Trends Driving The Growth Of The Organoids Market?

Technological progress is a prominent development gaining traction within the organoid market. Key companies active in the organoid market are introducing new organoid technologies to uphold their market presence. For example, in March 2023, MIMETAS, a Netherlands-based developer of human tissue and disease models, unveiled a novel variant of adult stem cell (ASC)-derived tubular organoids, integrated into its OrganoReady product line. This innovative organoid incorporates advanced and inventive technology for applications in mechanistic toxicology and drug-induced organ injury. These organoids are created as perfused 3D tubular structures, providing access points on their apical and basal sides, utilizing the OrganoPlate, a patented microfluidic platform.

Who Are The Top Performing Companies In The Organoids Market In Recent Years?

Major companies operating in the organoids market include Cellesce Ltd., STEMCELL Technologies, HUB Organoids, DefiniGEN, 3Dnamics Inc., OcellO B.V., Organoid Therapeutics, PeproTech Inc., QGel SA, Corning Incorporated, Thermo Fisher Scientific, Trevigen Inc., Path BioAnalytics, R&D Systems, Merck KGaA, 3D BioMatrix Inc., 3D Biotek LLC, AMS Biotechnology (Europe) Limited, Greiner Bio-One, 3-D Matrix, InSphero AG, Synthego Corporation, Axol Bioscience Ltd., TissUse GmbH, CytoSMART Technologies BV, EMD Millipore Corporation, Epithelix Sàrl

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/organoids-global-market-report

Which Region Is Expected To Witness The Fastest Growth In The Organoids Market?

North America was the largest region in the organoids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global organoids market size forecast period. The regions covered in the organoids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Organoids Market Report:

https://www.thebusinessresearchcompany.com/customise?id=10787&type=smp

Browse Through More Reports Similar to the Global Organoids Market 2025, By The Business Research Company

Cell And Genes Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cell-and-genes-therapy-global-market-report

Cell Culture Consumables And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cell-culture-consumables-and-equipment-global-market-report

Cell Cultures Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cell-cultures-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795